Overall rank by patents
#31,416
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 11 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
DTEN holds 8 US patents across 11 technology areas, rank #31,416 of 50,000 tracked assignees.
DTEN, Inc. has been granted 8 US utility patents between 2021 and 2025, placing DTEN, Inc. at rank #31,416 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.0 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a US Corporation, DTEN, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, DTEN sits between DRUG Delivery Co., Llc. (8 patents, rank #31,412) and Dymax Corporation (8 patents, rank #31,420) - the closest US assignees by grant volume. The composite Innovation Score of 50.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. DTEN, Inc.'s 19.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark DTEN, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
DRUG DELIVERY CO., LLC.
8 patents
DRYCODE GEAR LLC
8 patents
DSA International, LLC
8 patents
DSilo Inc.
8 patents
DUPONT TEIJIN ADVANCED PAPERS (JAPAN), LTD.
8 patents
DURA AUTOMOTIVE HOLDINGS U.K., LTD
8 patents
DXO LABS
8 patents
DYMAX CORPORATION
8 patents
DTEN, Inc.
8 patents
What this shows DTEN holds 8 patents at rank #31,416, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,416 in granted patent volume.
Other assignees with the most granted patents in DTEN's primary technology class.
DTEN's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 12.5% |
| 2022 | 6 | 75.0% |
| 2025 | 1 | 12.5% |
Top 11 of 11 technology areas
Overall rank by patents
#31,416
Across all tracked assignees
50.7 out of 100
How to use this portfolio
DTEN's 8 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.